Published on Wednesday, February 17, 2016 by Common Dreams by Lauren McCauley, staff writer Amid growing international concern over the health risks posed by Monsanto weedkiller glyphosate, the U.S. Food and Drug Administration (FDA) will reportedly begin testing for the herbicide this year. After speaking with FDA officials, Civil Eats reported Wednesday that the agency will begin testing for […]
The FDA has refused to reveal the names of any of the approximately 100 drugs affected by the fraud at the Houston lab of the firm Cetero Research, saying that to do so would reveal confidential commercial information.
FDA slow to address earlier instance of scientific misconduct at another contract research organization, MDS Pharma Services.
About 100 drugs, including sophisticated chemotherapy compounds and addictive prescription painkillers, had been approved for sale in the United States at least in part on the strength of Cetero Houston’s tainted tests.